Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, China.
Front Endocrinol (Lausanne). 2023 Jan 16;13:1105957. doi: 10.3389/fendo.2022.1105957. eCollection 2022.
Frailty and diabetes are two important health problems associated with aging in older individuals. This paper seeks to analyze the frailty in older adults suffering from diabetes and the combined effect of diabetes and frailty on mortality risk.
The frailty index (FI) model was employed when evaluating frailty among the older adults based on the baseline data conducted in 2009; and death as outcome variables collected in 2020 were analyzed. The influence of diabetes on age-related changes in frailty in the older adults and resulting mortality rates was analyzed. Cox regression and Kaplan-Meier curves were applied to evaluate the influence on the risk of death and the 11-year survival of the older adults with varying diabetes and frailty statuses.
Ultimately, 1,213 older people aged between 60 and 101, with an average age of (74.79 ± 8.58) at baseline, were included in the analysis. By 2020, there had been 447 deaths with mortality at 36.9% (447/1,213); there were 271 cases of diabetes, with a prevalence of 22.3% (271/1,213). The mean FI value for older adults with diabetes was higher than that of those without regardless of age, and the average annual relative growth rate of the FI value for older adults with diabetes was higher than that of those without diabetes ( 0.039 0.035 8.367, 0.001). For all FI value levels, the mortality rate among older adults with diabetes was higher than that of those without. The Cox Regression analysis showed that, compared with those suffering from neither diabetes nor frailty, older adults with both had the higher mortality risk ( = 1.760. P 0.001), followed by older adults suffering from frailty alone ( = 1.594, = 0.006), and then by older adults suffering from only diabetes ( = 1.475, = 0.033). The survival analysis showed that the median survival of those suffering from diabetes and frailty to be the shortest at just 57.23 (95% : 54.05 to 60.41) months, lower than the 83.78 (95% : 79.33 to 88.23) months in those suffering from frailty alone, and 119.93 (95% : 113.84 to 126.02) months in those with only diabetes, and 124.39 (95% : 119.76 to 129.02) months in older adults with neither diabetes nor frailty ( 0.001).
Frailty is common among older adults suffering from diabetes, and there is an increased risk of poor health outcomes, such as death, among older adults suffering from diabetes and frailty. When diagnosing, treating, and dealing with older adults with diabetes, attention should be paid to screening and assessing frailty in hopes of identifying it early so that appropriate measures of intervention can be taken to avoid or delay the resulting adverse effects.
衰弱和糖尿病是与老年人相关的两个重要健康问题。本文旨在分析老年糖尿病患者的衰弱状况,以及糖尿病和衰弱对死亡率的综合影响。
基于 2009 年基线数据,采用衰弱指数(FI)模型评估老年人的衰弱情况;并分析 2020 年收集的死亡作为结局变量。分析了糖尿病对老年人与年龄相关的衰弱变化以及由此导致的死亡率的影响。应用 Cox 回归和 Kaplan-Meier 曲线评估不同糖尿病和衰弱状态的老年人的死亡风险和 11 年生存率的影响。
最终,纳入了 1213 名年龄在 60 至 101 岁之间、平均年龄为(74.79±8.58)岁的老年人进行分析。到 2020 年,有 447 人死亡,死亡率为 36.9%(447/1213);有 271 例糖尿病,患病率为 22.3%(271/1213)。无论年龄大小,患有糖尿病的老年人的 FI 值平均值均高于未患糖尿病的老年人,患有糖尿病的老年人 FI 值的平均年相对增长率也高于未患糖尿病的老年人(0.039 vs 0.035,8.367, 0.001)。在所有 FI 值水平中,患有糖尿病的老年人的死亡率均高于未患糖尿病的老年人。Cox 回归分析表明,与既不患糖尿病也不衰弱的老年人相比,同时患有糖尿病和衰弱的老年人死亡率更高( = 1.760, P 0.001),其次是仅衰弱的老年人( = 1.594, = 0.006),然后是仅患有糖尿病的老年人( = 1.475, = 0.033)。生存分析表明,同时患有糖尿病和衰弱的老年人的中位生存期最短,仅为 57.23 个月(95%:54.05 至 60.41),低于仅衰弱的老年人的 83.78 个月(95%:79.33 至 88.23),低于仅患有糖尿病的老年人的 119.93 个月(95%:113.84 至 126.02),也低于既不患糖尿病也不衰弱的老年人的 124.39 个月(95%:119.76 至 129.02)( 0.001)。
衰弱在老年糖尿病患者中很常见,患有糖尿病和衰弱的老年人健康状况较差,如死亡的风险增加。在诊断、治疗和处理患有糖尿病的老年人时,应注意筛查和评估衰弱情况,以期尽早发现,从而采取适当的干预措施,避免或延迟由此产生的不良后果。